Zymeworks News

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, May 28, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the

GlobeNewswireMay 28 05:30

Stifel Nicolaus Reaffirms Their Buy Rating on Zymeworks (ZYME)

TipRanksMay 8 21:07

Zymeworks Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Zymeworks Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow JonesMay 7 05:31

HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $10 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Neutral and maintains $10 price target.

BenzingaMay 7 05:21

Zymeworks Price Target Cut to $16.00/Share From $17.00 by Citigroup

Zymeworks Price Target Cut to $16.00/Share From $17.00 by Citigroup

Dow JonesMay 3 17:06

Citi: Maintains the Zymeworks (ZYME.US) rating, adjusted from buy to buy rating, and adjusted the target price from $17.00 to $16.00.

Citi: Maintains the Zymeworks (ZYME.US) rating, adjusted from buy to buy rating, and adjusted the target price from $17.00 to $16.00.

Zhitong FinanceMay 3 17:01

Zymeworks Is Maintained at Overweight by Wells Fargo

Zymeworks Is Maintained at Overweight by Wells Fargo

Dow JonesMay 3 13:14

Wells Fargo Maintains Overweight on Zymeworks, Lowers Price Target to $12

Wells Fargo analyst Derek Archila maintains Zymeworks (NASDAQ:ZYME) with a Overweight and lowers the price target from $14 to $12.

BenzingaMay 3 13:04

Zymeworks Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 33.33% Wells Fargo $14 → $12 Maintains Overweight 03/12/2024 55.56% Wells Fargo $12 → $14 Maint

BenzingaMay 3 13:03

Zymeworks Inc. (NYSE:ZYME) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 3 09:26

Here's Why We're Not Too Worried About Zymeworks' (NASDAQ:ZYME) Cash Burn Situation

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a ne

Simply Wall StMay 3 07:42

Earnings Call Summary | Zymeworks(ZYME.US) Q1 2024 Earnings Conference

The following is a summary of the Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript:Financial Performance:Zymeworks reported a net loss of $31.7 million, or a loss of $0.42 per diluted share, for

Futu NewsMay 3 07:38 · Conference Call

Buy Rating Affirmed for Zymeworks on Strong Pipeline and Upcoming Catalysts

TipRanksMay 3 05:40

Zymeworks Inc (ZYME) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...

Yahoo FinanceMay 3 03:07

Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript

Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 2 19:04

Zymeworks Files Automatic Mixed Securities Shelf

Seeking AlphaMay 2 15:47

Zymeworks Touts Financial Health and R&D Progress

TipRanksMay 2 15:38

Zymeworks Q1 2024 GAAP EPS $(0.42) Misses $(0.29) Estimate, Sales $10.030M Miss $17.431M Estimate

Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.29) by 44.83 percent. This is a 13.51 percent decrease over losses of $(0.37) pe

BenzingaMay 2 15:27

Zymeworks Inc Stresses Transparency in Investor Communications

TipRanksMay 2 15:26

Press Release: Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results

Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results -- Reported $420.5 million in cash resources as of March 31, 2024, which when combined with certain antic

Dow JonesMay 2 15:05